Evidence map›Paper›PMID 36233148›Full record

ArticleInternational journal of molecular sciences2022

Amyloid Aβ

Alexander V Maltsev, Anna B Nikiforova, Natalia V Bal, Pavel M Balaban

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. ISR Modulators in Neurological Diseases.Current neuropharmacology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexander V MaltsevInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Butlerova 5A, 117485 Moscow, Russia.ORCID 0000-0002-2836-336X
Anna B NikiforovaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, Pushchino, 142290 Moscow, Russia.ORCID 0000-0003-4095-6560
Natalia V BalInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Butlerova 5A, 117485 Moscow, Russia.ORCID 0000-0002-5894-9548
Pavel M BalabanInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Butlerova 5A, 117485 Moscow, Russia.ORCID 0000-0001-9248-8207
Institute of Higher Nervous Activity and Neurophysiology · RUInstitute of Theoretical and Experimental Biophysics · RU

Funding

Russian Ministry of Science and High Education 075-15-2020-801
6 · The paper itself

Abstract

The search for strategies for strengthening the synaptic efficiency in Aβ

Indexed as

AmyloidosisLong-Term PotentiationAmyloidogenic ProteinsCantharidinCyclosporineHippocampusHumansMitochondriaNitric OxideOkadaic AcidPhosphoprotein PhosphatasesReactive Oxygen SpeciesSerineSodium-Calcium ExchangerThreonineAmyloidogenic ProteinsCantharidinCyclosporineNitric OxideOkadaic AcidPhosphoprotein PhosphatasesReactive Oxygen SpeciesSerineSodium-Calcium ExchangerThreonineAlzheimer’s diseaseamyloid peptidesfield excitatory postsynaptic potentialsmitochondrial Na+/Ca2+ exchangernitric oxideserine/threonine phosphatases

Identifiers

PMID36233148
PMCPMC9570122
OpenAlexW4303699266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.